Drug details

Nexletol (bempedoic acid tablets, for oral use)

type of Lipid-Lowering Agents, ACL Inhibitors

Nexletol (bempedoic acid) is an adenosine triphosphate-citrate lyase (ACL) inhibitor used as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C.

This drug may have the following side effects:

• upper respiratory tract infection,
• back pain,
• muscle spasms,
• anemia, and
• pain in extremities,
• bronchitis,
• high levels of uric acid in the blood,
• abdominal pain or discomfort,
• elevated liver enzymes

The following drugs are related to Nexletol, either as a replacement or used together:

• Lipitor (atorvastatin calcium)
• Welchol (colesevelam hcl)
• Crestor (rosuvastatin calcium)
• Vytorin (ezetimibe and simvastatin)
• Zetia (ezetimibe tablets)
• Lescol (fluvastatin sodium)
• Leqvio (inclisiran injection)
• Livalo (pitavastatin)
• Lovaza (omega-3-acid ethyl esters)
• Pravachol (pravastatin sodium)
• Zocor (simvastatin)